Document Detail


Acute coronary artery vasospasm associated with misoprostol for termination of pregnancy.
MedLine Citation:
PMID:  20224253     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prostaglandin E(1) analogues, gemeprost and misoprostol, are the most widely used drugs for medical termination of pregnancy within the first two trimesters of pregnancy. Gemeprost has been reported to be associated with acute cardiovascular accidents in a few cases, but no adverse cardiovascular events have been reported with misoprostol. For this reason, misoprostol has been considered a potentially safer drug and is widely recommended as a first-choice drug in combination with mifepristone. We report a case of a 32-year-old woman with active smoking and obesity, who developed an episode of transient acute coronary artery vasospasm following the administration of intravaginal misoprostol. This report illustrates that misoprostol can also be associated with acute coronary events, although it remains to be evaluated whether the risk is similar or lower to gemeprost.
Authors:
Miriam Illa; Mar Bennasar; Elisenda Eixarch; Raquel Berge; Carme Font; Montse Palacio
Related Documents :
7924323 - Ru486 combined with pge1 analog in voluntary termination of early pregnancy--a comparis...
1701323 - Changes in circulating alphafetoprotein following administration of mifepristone in fir...
10729753 - Transport and metabolism of serotonin in the human placenta from normal and severely pr...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-03-11
Journal Detail:
Title:  Fetal diagnosis and therapy     Volume:  27     ISSN:  1421-9964     ISO Abbreviation:  Fetal. Diagn. Ther.     Publication Date:  2010  
Date Detail:
Created Date:  2010-04-23     Completed Date:  2010-07-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107463     Medline TA:  Fetal Diagn Ther     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  174-7     Citation Subset:  IM    
Copyright Information:
Copyright 2010 S. Karger AG, Basel.
Affiliation:
Department of Maternal-Fetal Medicine, Institut Clínic de Ginecologia, Obstetrícia i Neonatologia (ICGON), Hospital Clinic, University of Barcelona, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage,  adverse effects*
Abortion, Induced / adverse effects*
Adult
Alprostadil / adverse effects,  analogs & derivatives
Analgesics / therapeutic use
Chest Pain / drug therapy
Coronary Vasospasm / chemically induced,  diagnosis*
Coronary Vessels / drug effects*,  physiopathology
Female
Humans
Ketoprofen / analogs & derivatives,  therapeutic use
Mifepristone / adverse effects
Misoprostol / administration & dosage,  adverse effects*
Pregnancy
Pregnancy Trimester, Second / drug effects
Tromethamine / analogs & derivatives,  therapeutic use
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 0/Analgesics; 0/dexketoprofen trometamol; 22071-15-4/Ketoprofen; 59122-46-2/Misoprostol; 64318-79-2/gemeprost; 745-65-3/Alprostadil; 77-86-1/Tromethamine; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Finger force coordination underlying object manipulation in the elderly - a mini-review.
Next Document:  The Relation between Plasma Tissue Factor and Oxidized LDL Levels in Acute Coronary Syndromes.